Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis

Cited by (453)

Items 301–400 of 453

1. Rapid detection of alteration of serum IgG in patients with schizophrenia after risperidone treatment by matrix‐assisted laser desorption ionization/time‐of‐flight mass spectrometry
   Li‐Hua Lo, Jentaie Shiea, Tiao‐Lai Huang · 2016 · Rapid Communications in Mass Spectrometry
2. Peripheral Blood Levels of Brain-Derived Neurotrophic Factor in Patients with First Episode Psychosis: A Systematic Review and Meta-Analysis
   Sukhbir Singh, Dipta Roy, Taylor Marzouk, Jianping Zhang · 2022 · Brain Sciences
3. Spironolactone alleviates schizophrenia-related reversal learning in Tcf4 transgenic mice subjected to social defeat
   Marius Stephan, Jonathan Schoeller, Florian J. Raabe, Andrea Schmitt, Alkomiet Hasan, Peter Falkai, Niels Jensen, Moritz J. Rossner · 2022 · Schizophrenia
4. Improving Cognition via Exercise (ICE): Study Protocol for a Multi-Site, Parallel-Group, Single-Blind, Randomized Clinical Trial Examining the Efficacy of Aerobic Exercise to Improve Neurocognition, Daily Functioning, and Biomarkers of Cognitive Change in Individuals with Schizophrenia
   L. Ospina, M. Wall, L. Jarskog, Jacob S. Ballon, J. McEvoy, M. Bartels, R. Buchsbaum, R. Sloan, T. Stroup, D. Kimhy · 2019 · Journal of Psychiatry and Brain Science
5. BDNF Gene Polymorphism, Cognition and Symptom Severity in a Brazilian Population-Based Sample of First-Episode Psychosis Subjects
   Eduardo Martinho, Leandro Michelon, Adriana M. Ayres, Márcia Scazufca, Paulo Rossi Menezes, Maristela S. Schaufelberger, Robin M. Murray, Teresa Rushe, Homero Vallada, Geraldo F. Busatto · 2012 · Brazilian Journal of Psychiatry
6. Brain Development
   Robbin L. Gibb, Anna Kovalchuk · 2017 · Elsevier eBooks
7. Schizophrenia, Curcumin and Minimizing Side Effects of Antipsychotic Drugs: Possible Mechanisms
   Rabiee, Reyhaneh, Hosseini Hooshiar, Saeedeh, Ghaderi, Amir, Jafarnejad, Sadegh · 2023 · Neurochemical Research
8. Long-term effects of prenatal stress on the development of prefrontal cortex in the adolescent offspring
   Arbthip Suwaluk, Nuanchan Chutabhakdikul · 2022 · Journal of Chemical Neuroanatomy
9. The emerging role of exosomes in Schizophrenia
   Jie Dai, Minzhe Zhang, Qi‐qiang He, Rui Chen · 2023 · Psychiatry Research
10. Brain‐derived neurotrophic factor levels in perinatal depression: A systematic review and meta‐analysis
    Kyana Jafarabady, Arman Shafiee, Razman Arabzadeh Bahri, Shahryar Rajai Firouzabadi, Ida Mohammadi, Mohammad Javad Amini · 2023 · Acta Psychiatrica Scandinavica
11. Levels of Serum Brain-Derived Neurotrophic Factor in Schizophrenia
    Jimmy Lee, Milawaty Nurjono, Tih-Shih W. Lee · 2016 · The Journal of Nervous and Mental Disease
12. Effects of physical activity on delayed memory measures in randomized controlled trials with nonclinical older, mild cognitive impairment, and dementia participants
    Philip Gerard Gasquoine · 2018 · Journal of Clinical and Experimental Neuropsychology
13. Elevated brain-derived neurotrophic factor (BDNF) serum levels in an acute episode of schizophrenia in polish women: Correlation with clinical and metabolic parameters.
    Maria Skibińska, Paweł Kapelski, Aleksandra Rajewska‐Rager, Aleksandra Szczepankiewicz, Beata Narożna, Joanna Duda, Bartłomiej Budziński, Joanna Hauser, Monika Dmitrzak‐Węglarz, Joanna Pawlak · 2018 · Psychiatry Research
14. Effects of Exercise on Serum Triglycerides and Symptoms of Schizophrenia
    David D. Kim, Donna J. Lang, Darren E. R. Warburton, Alasdair M. Barr, Geoffrey N. Smith, Allen E. Thornton, Randall F. White, William G. Honer, Ric M. Procyshyn · 2017 · Journal of Clinical Psychopharmacology
15. Rethinking the studies of diagnostic biomarkers for mental disorders
    Jin Liu, Haoting Wang, Lingjiang Li · 2025 · Meta-Radiology
16. IUPHAR review – Novel therapeutic targets for schizophrenia treatment: A translational perspective
    Veronica Begni, Alessia Marchesin, Marco Andrea Riva · 2025 · Pharmacological Research
17. Cannabis use influence on peripheral brain-derived neurotrophic factor levels in antipsychotic-naïve first-episode psychosis
    Alba Toll, Daniel Bergé, Keith Burling, Linda Scoriels, Devi Treen, Clara Monserrat, F. Màrmol, Xavier Durán, Peter Brian Jones, Víctor Pérez et al. · 2020 · European Archives of Psychiatry and Clinical Neuroscience
18. Relationship of Brain-Derived Neurotrophic Factor with Interleukin-23, Testosterone and Disease Severity in Schizophrenia
    Priya Allimuthu, Hanumanthappa Nandeesha, Raghavi Chinniyappan, Balaji Bhardwaz, Blessed Raj Jesudas · 2020 · Indian Journal of Clinical Biochemistry
19. BDNF and Cognitive Function in Chilean Schizophrenic Patients
    Rodrigo R. Nieto, Hernán Silva I, Alejandra Armijo, Rubén Nachar, Alfonso González, Carmen Paz Castañeda, Cristián Montes, Manuel Kukuljan P · 2023 · International Journal of Molecular Sciences
20. Serum brain-derived neurotrophic factor levels and psychotic symptoms in heroin dependence
    Bin Han, X.Y. Zhang, D.Y. Wang, Wenwei Ren, Yingying Gu, Lina Zhu, Yih‐Leong Chang, L.P. Wang, Cunzao Wu, Q.Q. Jin et al. · 2015 · Comprehensive Psychiatry
21. Interplay of Brain-Derived Neurotrophic Factor and Cytokines in Schizophrenia
    Slavica Minic Janicijevic, Slavica Djukic Dejanovic, Milica Borovčanin · 2018 · Serbian Journal of Experimental and Clinical Research
22. Altered serum levels of glial cell line‐derived neurotrophic factor in male chronic schizophrenia patients with tardive dyskinesia
    Fei Ye, Qiongqiong Zhan, Wenhuan Xiao, Weiwei Sha, Xiaobin Zhang · 2018 · International Journal of Methods in Psychiatric Research
23. Genes implicated by a methylome-wide schizophrenia study in neonatal blood show differential expression in adult brain samples
    Edwin J. C. G. van den Oord, Lin Ying Xie, Min Zhao, Thomas L. Campbell, Gustavo Turecki, Anna K. Kähler, Brian Dean, Ole N Mors, Christina M. Hultman, Nicklas Heine Staunstrup et al. · 2023 · Molecular Psychiatry
24. Effect of cannabis use on blood levels of brain‐derived neurotrophic factor (BDNF) and nerve growth factor (NGF): A systematic review and meta‐analysis
    Arman Shafiee, Mohammad Ali Rafiei, Kyana Jafarabady, Alireza Eskandari, Faeze Soltani Abhari, Mohammad Amin Sattari, Mohammad Javad Amini, Mahmood Bakhtiyari · 2023 · Brain and Behavior
25. Neurotrophic Factors in Cannabis-induced Psychosis: An Update
    Valerio Ricci, Domenico De Berardis, Giovanni Martinotti, Giuseppe Maina · 2023 · Current Topics in Medicinal Chemistry
26. In Silico Model-driven Assessment of the Effects of Brain-derived Neurotrophic Factor Deficiency on Glutamate and Gamma-Aminobutyric Acid: Implications for Understanding Schizophrenia Pathophysiology
    Rimjhim Agrawal, S. Kalmady, G. Venkatasubramanian · 2017 · Clinical Psychopharmacology and Neuroscience
27. Effects of haloperidol and clozapine on synapse-related gene expression in specific brain regions of male rats
    Martina von Wilmsdorff, Fabian Manthey, Marie-Luise Bouvier, Oliver Staehlin, Peter Falkai, Eva Meisenzahl‐Lechner, Andrea Schmitt, Peter J. Gebicke‐Haerter · 2018 · European Archives of Psychiatry and Clinical Neuroscience
28. Frontotemporal Transcranial Direct Current Stimulation Decreases Serum Mature Brain-Derived Neurotrophic Factor in Schizophrenia
    Ondine Adam, Marion Psomiades, Romain Rey, Nathalie Mandairon, Marie‐Françoise Suaud‐Chagny, Marine Mondino, Jérôme Brunelin · 2021 · Brain Sciences
29. The Protein-Protein Interaction Network of First Episode Psychosis and Schizophrenia Reveals Possible Trigger Factors and New Drug Targets among Intracellular Signal Transduction Pathways and Neurotoxicity Processes
    Michael Maes, Kitiporn Plaimas, Apichat Suratanee, Cristiano de Souza Noto, Buranee Kanchanatawan · 2021 · Preprints.org
30. Is it possible to prevent excessive synaptic pruning in schizophrenia? Possibilities and limitations
    Agnieszka Pawlak, Jakub Stefanowicz, Zofia Kotkowska, Agata Gabryelska, Marcin Sochal, Filip Napieraj, Magdalena Kotlicka‐Antczak, Dominik Strzelecki · 2025 · Frontiers in Synaptic Neuroscience
31. Changes in serum levels of brain-derived neurotrophic factor with electroconvulsive therapy and pharmacotherapy and its clinical correlates in male schizophrenia patients
    Ibrahim Akbas, Özlem Devrim Balaban · 2021 · Acta Neuropsychiatrica
32. BDNF Serum Levels are Associated With White Matter Microstructure in Schizophrenia - A Pilot Study
    Christine Hammans, Kristina Neugebauer, Vinod Kumar, Lea Mevissen, Melanie A. Sternkopf, Ana M. Novakovic, Tobias Wensing, Ute Habel, Ted G. Abel, Thomas Nickl‐Jockschat · 2020 · Frontiers in Psychiatry
33. Current Methodological Pitfalls and Caveats in the Assessment of Exercise-Induced Changes in Peripheral Brain-Derived Neurotrophic Factor: How Result Reproducibility Can Be Improved
    Chiara Nicolini, Aimee Jennifer Nelson · 2021 · Frontiers in Neuroergonomics
34. BDNF and S100B in psychotic disorders: evidence for an association with treatment responsiveness
    Noortje W.A. van de Kerkhof, Durk Fekkes, Frank M. M. A. Van der Heijden, Willem M. A. Verhoeven · 2013 · Acta Neuropsychiatrica
35. Schneiderian first rank symptoms in schizophrenia: A developmental neuroscience evaluation
    Sai Krishna Tikka, S. Haque Nizamie, Archana Kumari Das, Nidhi Agarwal, Nishant Goyal · 2016 · International Journal of Developmental Neuroscience
36. Evaluation of the Relationship between Brain-Derived Neurotropic Factor Levels and the Stroop Interference Effect in Children with Attention-Deficit Hyperactivity Disorder.
    Ş. Şimşek, Salih Gençoğlan, T. Yüksel, İ. Kaplan, Huseyin Aktas, Rümeysa Alaca · 2016 · Nöropsikiyatri arşivi
37. The Imbalanced Plasticity Hypothesis of Schizophrenia-Related Psychosis: A Predictive Perspective
    Yossi Guterman, Yochai Ataria, Steven M. Silverstein · 2021 · Cognitive Affective & Behavioral Neuroscience
38. A novel commentary: Investigation of the role of a balance between neurotrophic and apoptotic proteins in the pathogenesis of psychosis via the tPA-BDNF pathway
    Ümit Haluk Yeşilkaya, Şakir Gıca, Büşra Güney Taşdemir, Pelin Ozkara Menekseoglu, Zeynep Cirakli, Nesrin Karamustafalıoğlu · 2021 · Journal of Psychiatric Research
39. Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis
    Alba Toll, Laura Blanco‐Hinojo, Daniel Bergé, Xavier Durán, Irene Canosa, Teresa Legido, F. Màrmol, Víctor Pérez, Emilio Fernández-Egea, Anna Mané · 2022 · Journal of Psychiatry and Neuroscience
40. Daily-Life Physical Activity of Healthy Young Adults Associates With Function and Structure of the Hippocampus
    Sara Seoane, Laura Ezama, Niels Janssen · 2022 · Frontiers in Human Neuroscience
41. Cocaine-induced Psychosis and Brain-derived Neurothrophic Factor in Patients with Cocaine Dependence: Report of Two Cases
    Carlos Roncero, Raúl Felipe Palma-Álvarez, Elena Ros‐Cucurull, Carmen Barral, Begoña Gonzalvo, Margarida Corominas, Miguel Casas, Lara Grau‐López · 2016 · Clinical Psychopharmacology and Neuroscience
42. Diagnostic Accuracy of Brain-derived Neurotrophic Factor and Nitric oxide in Patients with Schizophrenia. A pilot study/ Dijagnostička tačnost moždanog neurotrofičkog faktora i azot-monoksida kod obolelih od shizofrenije.Pilot studija
    Vidosava B. Djordjević, D.S. Lazarevic, Vladan Ćosić, Marinela Z. Knezevic, Vidosava B. Djordjević, Ivana R. Stojanović, Vladimir Djorgevič · 2015 · Journal of Medical Biochemistry
43. Yoga for Schizophrenia: a Review of Efficacy and Neurobiology
    Dodell-Feder, David, Gates, Annesly, Anthony, Donna, Agarkar, Smita · 2017 · Current Behavioral Neuroscience Reports
44. Neurochemical evidence that cysteamine modulates amphetamine-induced dopaminergic neuronal activity in striatum by decreasing dopamine release: an in vivo microdialysis study in freely moving rats.
    A. Rakovska, D. Javitt, P. Petkova-Kirova, A. Balla, Rosalind L. Ang, R. Kalfin · 2019 · Brain Research Bulletin
45. Ketamine and olanzapine alter behaviour and prefrontal-cortex BDNF differentially in male and female rats
    Kalin Manooki, Mahdieh Gholami, Maryam Eslami, Salar Vaseghi, Batool Ghorbani Yekta · 2025 · Scientific Reports
46. Novel α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid receptor ( AMPAR ) potentiator LT ‐102: A promising therapeutic agent for treating cognitive impairment associated with schizophrenia
    Xueyu Qi, Xueli Yu, Wei Long, Han Jiang, Jiangwen Dong, Hongxing Li, Yingying Wei, Liansheng Zhao, Wei Deng, Wanjun Guo et al. · 2024 · CNS Neuroscience & Therapeutics
47. Neuroendocrine characterization into schizophrenia: norepinephrine and melatonin as promising biomarkers
    Junwei Shen, Xin Li, Yinghua Zhong, Jiechun Zhang, Hongyun Qin, Fazhan Chen, Xudong Zhao · 2025 · Frontiers in Endocrinology
48. Fibroblast Growth Factor 9 as a Potential Biomarker for Schizophrenia
    Xiaoling Li, Yun Yu, Yang Hu, Huantong Wu, Xue-Song Li, Guang-Yang Chen, Yong Cheng · 2022 · Frontiers in Psychiatry
49. Lower Serum Tropomyosin Receptor Kinase B Levels in Patients with Schizophrenia
    Tiao-Lai Huang, Yi-Yung Hung · 2013 · Biomedical Journal
50. The Association Between Cardiorespiratory Fitness and Cognition Appears Neither Related to Current Physical Activity Nor Mediated by Brain-Derived Neurotrophic Factor in a Sample of Outpatients With Schizophrenia
    Tom Langerud Holmen, Jens Egeland, Eivind Andersen, Jon Mordal, Ole A. Andreassen, Thor Ueland, Therese Torgersen Bigseth, Gry Bang-Kittilsen, John Abel Engh · 2019 · Frontiers in Psychiatry
51. A Longitudinal Study of Serum Brain-Derived Neurotrophic Factor Levels in First-Episode Schizophrenia
    Jie Yin Yee, Tih-Shih W. Lee, Jimmy Lee · 2019 · Journal of Clinical Psychopharmacology
52. Biomarkers in the diagnosis of neurodegenerative diseases
    Syed Haque · 2022 · RUDN Journal of Medicine
53. Higher blood MLL1 mRNA and BDNF promoter IV on histone H3K4me3 levels in patients with schizophrenia
    Tiao‐Lai Huang, Chin-Chuen Lin, Rong‐Fu Chen, Chien‐Te Lee · 2016 · Psychiatry Research
54. The relationship between the brain-derived neurotrophic factor and neurocognitive response to physical exercise in individuals with schizophrenia
    Gry Bang-Kittilsen, Jens Egeland, Thor Ueland, Eivind Andersen, Therese Torgersen Bigseth, Tom Langerud Holmen, Jon Mordal, René Holst, John Abel Engh · 2023 · Psychoneuroendocrinology
55. Effects of curcumin nanodelivery on schizophrenia and glioblastoma
    Susana Bulnes, Marina Picó-Gallardo, Harkaitz Bengoetxea, José Vicente Lafuente · 2023 · International review of neurobiology
56. Exercise as an Adjuvant Treatment of Schizophrenia: A Review
    Muhammad S Abbas, Sondos T Nassar, Tasniem Tasha, Anjali Varma Desai, Anjana Bajgain, Asna Ali, Chandrani Dutta, Khadija Pasha, Salomi Paul, Sathish Venugopal · 2023 · Cureus
57. Brain-derived neurotrophic factor as a potential biomarker of cognitive recovery in schizophrenia
    Rafael Penadés · 2013 · World Journal of Psychiatry
58. Serum brain-derived neurotrophic factor (BDNF) and its association with remission status in Chinese patients with schizophrenia
    Vidhya Renjan, Milawaty Nurjono, Jimmy Lee · 2014 · Psychiatry Research
59. Relevance of Brain-derived Neurotrophic Factor Levels in Schizophrenia: A Systematic Review and Meta-Analysis
    Ian M Rowbotham, Franco F. Orsucci, Mohamed F Mansour, Samuel Robin Chamberlain, Haroon Y. Raja · 2015 · AIMS neuroscience
60. A Phase-1, 6-Month Open-Label, Dose-Ranging Pharmacokinetic Study in Stabilized Patients with Schizophrenia Following Risperidone Implant.
    Ryan Dammerman, Sonnie Kim, Mathews Adera, Alex Schwarz · 2017 · Europe PMC (PubMed Central) · Retracted
61. Hippocampal subfield volumes and change in body mass over 12 months of treatment in first-episode schizophrenia spectrum disorders
    Hilmar Klaus Luckhoff, Stefan S. du Plessis, Sanja Kilian, Laila Asmal, Freda Scheffler, Lebogang Phahladira, Riaan Olivier, Robin Alexander Emsley · 2020 · Psychiatry Research Neuroimaging
62. Suicide Reduction in Schizophrenia via Exercise (SUnRISE): study protocol for a multi-site, single-blind, randomized clinical trial of aerobic exercise for suicide risk reduction in individuals with schizophrenia
    Katie Beck-Felts, Marianne S. Goodman, Luz H. Ospina, Melanie M. Wall, Joseph P. McEvoy, L. Fredrik Jarskog, Jacob S. Ballon, Matthew N. Bartels, Richard Buchsbaum, Richard P. Sloan et al. · 2020 · Trials
63. Could Irisin Levels be Affected by Physical Activity in Patients with Schizophrenia?
    Gamze Erzın, Olga Güriz, Ali Yalçındağ, Akfer Karaoğlan Kahiloğulları, Sibel Örsel · 2021 · Clinical Psychopharmacology and Neuroscience
64. Paternal age and specific neurological soft signs as reliable and valid neurobiological markers for the diagnosis of patients with schizophrenia
    Konstantinos Ν. Fountoulakis, Panagiotis Panagiotidis, Thomas J. Tegos, Vasilios Κ. Kimiskidis, Ioannis Nimatoudis · 2021 · European Archives of Psychiatry and Clinical Neuroscience
65. Dysregulation of Fibroblast Growth Factor 10 in the Peripheral Blood of Patients with Schizophrenia
    Yun Yu, Guojun Xie, Yang Hu, Xue-Song Li, Guang-Yang Chen, Guang-En Zheng, Xi Chen, Yong Cheng · 2019 · Journal of Molecular Neuroscience
66. Brain‐derived neurotrophic factor levels and psychopathology scores in drug‐naïve first‐episode psychosis
    Mehmet Sinan Aydın, Abdullah Bolu, Muhammed Fevzi Kılınçkaya, Taner Öznur, Cemil Çelik, Özcan Uzun, Kami̇l Nahi̇t Özmenler · 2020 · Asia-Pacific Psychiatry
67. Incongruent Expression of Brain-Derived Neurotrophic Factor and Cortisol in Schizophrenia: Results from a Randomized Controlled Trial of Laughter Intervention
    Shu-Li Cheng, Fu‐Chi Yang, Hsuan‐Te Chu, Chia‐Kuang Tsai, Shih-Chieh Ku, Yu‐Ting Tseng, Ta‐Chuan Yeh, Chih‐Sung Liang · 2020 · Psychiatry Investigation
68. Differential effects of chronic adolescent glucocorticoid or methamphetamine on drug-induced locomotor hyperactivity and disruption of prepulse inhibition in adulthood in mice.
    Lina Schonfeld, E. Jaehne, A. Ogden, J. Spiers, Samuel Hogarth, M. van den Buuse · 2022 · Progress in Neuro-psychopharmacology and Biological Psychiatry
69. A systematic review of miRNA expression in schizophrenia spectrum disorders across the blood and the brain
    Marek Kotas, Bartłomiej Stańczykiewicz, Bartłomiej Sporniak, Edyta Pawlak, Błażej Misiak · 2025 · Neuroscience & Biobehavioral Reviews
70. Brain-derived neurotrophic factor prevents LPS-induced dysregulation of GABAergic interneuron markers in mouse hippocampus
    Sara Rezaei, Mounira Banasr, Thomas Damien Prevot, Yashika Bansal, Érica Leandro Marciano Vieira, Etienne L. Sibille · 2025 · Frontiers in Cellular Neuroscience
71. Association of serum brain-derived neurotrophic factor with hepatic enzymes, AST/ALT ratio, and FIB-4 index in middle-aged and older women
    Takumi Yokokawa, Shohei Sasaki, Kohei Sase, Naomi Yoshii, Jun Yasuda, Tatsuya Hayashi, Satoshi Fujita · 2022 · PLoS ONE
72. Brain-Derived Neurotrophic Factor (BDNF) and First-Episode Psychosis. A longitudinal one-year prognosis study.
    Silvia Yelmo-Cruz, A.M. Morera, Sunil Lakhwani, Pedro Abreu-González · 2023 · PubMed Central
73. Understanding the potential mechanisms of disease modifying effects of physical activity and exercise in people with schizophrenia
    Auwal Abdullahi, Thomson W. L. Wong, Shamay S. M. Ng · 2024 · Schizophrenia Research
74. Glial Derived Neurotrophic Factor and Schizophrenia Spectrum Disorders: A Scoping Review
    Valerio Ricci, Domenico De Berardis, Giovanni Martinotti, Giuseppe Maina · 2024 · Current Neuropharmacology
75. BDNF Levels According to Variations in the CACNA1C Gene: Sex-Based Disparity
    Clarissa Ribeiro Bastos, Janaína Xavier, Laísa Camerini, Samanta Seibt Dewes, Fernanda Pedrotti Moreira, Carolina David Wiener, Karen Jansen, Manuella Pinto Kaster, Luciano Dias de Mattos Souza, Ricardo Azevedo da Silva et al. · 2022 · Cellular and Molecular Neurobiology
76. Increase in Brain-derived Neurotrophic Factor in Patients with Schizophrenia Treated with Olanzapine: A Systemic Review and Meta-analysis
    Pao‐Yen Lin · 2012 · Journal of Experimental & Clinical Medicine
77. Depression in the structure of schizophrenia: clinical and biochemical characteristics
    Н. Н. Петрова, Цыренова Кристина Александровна, Mariia Dorofeikova · 2021 · S S Korsakov Journal of Neurology and Psychiatry
78. Epigenetic regulation of BDNF-TrkB signaling in the pathophysiology and treatment of mood disorders
    Fabien Boulle · 2013
79. Treatments for weight gain in schizophrenia
    Igor Elman · 2025 · Current Opinion in Psychiatry
80. Peripheral BDNF Levels in Individuals at Ultra-High Risk for Psychosis: A Systematic Review
    Omar Contreras, Carla Rivera, Carolina Villaseca, Francisco Mas, Benjamín Cartes, Rolando I Castillo-Passi, Rodrigo R. Nieto · 2025 · Brain Sciences
81. Molecular aspects of regeneration and neuroprotection in neuropsychiatric diseases
    A. A. Farooqui · 2020 · Elsevier eBooks
82. High blood levels of brain-derived neurotrophic factor (BDNF) mRNA in early psychosis are associated with inflammatory markers
    Irene Moreno, Alexander Stojanovic‐Pérez, Bengisu Kevser Bulduk, Vanessa Sánchez‐Gistau, María José Algora, Laura Ortega, Gerard Muntané, Elisabet Vilella, Javier Labad, Lourdes Martorell · 2023 · Journal of Psychiatric Research
83. Light Treatment Ameliorates Sub-chronic MK-801-Induced Cognitive Deficits in Mice Through Up-regulating BDNF/p-CREB/p-ERK Signaling Pathway
    Keke Cui, Yiying Zhou, Lizhi Zhang, Yudong Ying, Yan Xue, Xiaoqin Zhang, Qinwen Wang, Haowei Shen, Wenhua Zhou, Feng Gao et al. · 2024 · Molecular Neurobiology
84. The Potential Role of Exercise-Induced Neurotrophic Factors for Mental Health
    Yakup Zühtü Bırıncı · 2022 · IntechOpen eBooks
85. Brain-derived neurotrophic factor serum concentration and BDNF Val66Met polymorphism in patients with peripheral artery disease: the importance of heart failure
    Aleksandra Chyrek-Tomaszewska, Alicja Katarzyna Popiołek, Katarzyna Linkowska, Mariusz Kozakiewicz, Adam Szelągowski, Jacek Budzyński, Maciej Kazimierz Bieliński · 2023 · Medical Research Journal
86. Effets métaboliques indésirables des antipsychotiques
    Bruno Fève · 2013 · Obésité
87. Low BDNF concentrations in schizophrenia may be caused by non-linearity of BDNF correlation with age caused by its interaction with sex
    Maja Vilibić, Karolina Novački, Nada Vrkić, Dalibor Karlović · 2018 · Alcoholism
88. No significant association between brain-derived neurotrophic factor gene rs6265 and cognitive function in Japanese patients with schizophrenia
    Taro Kishi, Yasuhisa Fukuo, Masatsugu Moriwaki, Nakao Iwata, Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, Atsuko Ikenouchi, Kiyokazu Atake, Wakako Umene‐Nakano et al. · 2014 · Psychiatry Research
89. Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia
    P.F. Buckley, Brian J. Miller, Anilkumar Pillai, Brian W Kirkpatrick · 2014 · Schizophrenia Research
90. Do Benzodiazepines Plus Fluvoxamine Cause a Rapid Increase in Serum Brain-derived Neurotrophic Factor or Clinical Improvement in Major Depressive Disorder Patients?
    Asuka Katsuki, Yoshihisa Fujino, Hoa Le Nguyen, Reiji Yoshimura · 2018 · Neuropsychiatry
91. Neuroplasticity and Cognitive Training in Schizophrenia
    Sujita Kumar Kar, Amit Kumar Singh · 2019 · Current Behavioral Neuroscience Reports
92. Alterations in DNA methylation rates of brain-derived neurotrophic factor in patients with schizophrenia
    Shinji Nojima, Manabu Fuchikami, Tsutomu Kataoka, Motoaki Araki, Jun Omura, Tatsuhiro Miyagi, Yasumasa Okamoto, Akitoyo Hishimoto, Shigeru Morinobu · 2021 · The European Journal of Psychiatry
93. Exercise, Neuroplasticity, and Growth Factors in Adolescence
    Hélios Pareja-Galeano, Sara Mayero, Fabián Sanchis‐Gomar · 2015 · Wiley eBooks
94. Machine learning helps predict early onset psychosis with serum protein biomarkers, neuropsychometry, and clinicodemographic data
    P. Zakowicz, M. Brzezicki, Joanna Pawlak, M. Skibińska, Szymon J. Jurga, Aleksandra E. Lewandowska, B. Vogel, E. Ungermann, Barbara Remberk · 2025 · Scientific Reports
95. Serum brain-derived neurotrophic factor levels in patients with schizophrenia and methamphetamine addiction: correlation with Mini-Mental State Examination (MMSE)
    Saja Mahir Mohammed, Zainab Hassan Hashim, Mahir Mohammed Hussein, Qasim Sharhan Al-Mayah · 2023 · Journal of Medicine and Life
96. Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data
    Ulker Isayeva, Mirko Manchia, Roberto Collu, Diego Primavera, Luca Deriu, Edoardo Caboni, Maria Novella Iaselli, Davide Sundas, Massimo Tusconi, Federica Pinna et al. · 2024 · Schizophrenia Research
97. Aetiology and Risk Factors of Schizophrenia
    Adnan Kuşman · 2024 · IntechOpen eBooks
98. Do Long‐Acting Injectable Antipsychotics Influence Serum Levels of Brain‐Derived Neurotrophic Factor in People With Schizophrenia and Schizoaffective Disorder?
    Mirko Manchia, Ulker Isayeva, Roberto Collu, Diego Primavera, Luca Deriu, Edoardo Caboni, Maria Novella Iaselli, Davide Sundas, Massimo Tusconi, Clement C.H. Zai et al. · 2024 · Mental Illness
99. Multitrait Analysis to Decipher the Intertwined Genetic Architecture of Neuroanatomical Phenotypes and Psychiatric Disorders
    Antoine Auvergne, Nicolas Traut, Léo Henches, Lucie Troubat, Arthur Frouin, Christophe Boetto, Sayeh Kazem, Hanna Julienne, Roberto Toro, Hugues Aschard · 2024 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
100. Cerebrolysin Induces Dendritic Tree Plastic Changes and BDNF Increase in the Amygdala of Male Rats with Maternal Deprivation
     Jhonathan Cárdenas-Bedoya, Blanca Miriam Torres-Mendoza, Néstor I. Martínez-Torres · 2025 · Neurochemical Research